Post BMT patients are monitored for possible recurrence of their cancer and also for the development of secondary cancers (examples-skin cancers and bone marrow dysplasia).
- Your BMT and referring MD will be evaluating you for any post transplant related complications (GVHD, thyroid problems, secondary cancers, etc.) that may have developed.
- Patients will be required to return to the NSH-BMT Program for post transplant evaluation studies at the following intervals: 100 days, 6 months, 1 year, 18 months, 2 years, 3 years and depending on the disease and type of transplant, possibly annually for 5 years.
- Your BMT coordinator/team will coordinate your post BMT evaluation studies with you. You will be given an evaluation schedule specific to you at the time of discharge or when you have reached at least 100 days following transplant.
Your BMT physician will communicate with you and your referring physician the results of your post transplant evaluation studies and any recommendations for follow up care.
You will also be asked to complete vaccinations beginning as early as 6 months post transplant. Your coordinator will provide you with a specific vaccination schedule catered to you. Please refer to Vaccinations Recommended for Both Autologous and Allogeneic HCT Recipients.